# FDA Inspection 1001627 - Otsuka Pharmaceutical Development & Commercialization, Inc. - February 03, 2017

Source: https://www.keypedia.com/records/fda_inspections/otsuka-pharmaceutical-development-commercialization-inc/09830207-43b4-4cd1-b5a1-4879df06423d
Source feed: FDA_Inspections

> FDA Inspection 1001627 for Otsuka Pharmaceutical Development & Commercialization, Inc. on February 03, 2017. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1001627
- Company Name: Otsuka Pharmaceutical Development & Commercialization, Inc.
- Inspection Date: 2017-02-03
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1276733 - 2025-06-25](https://www.keypedia.com/records/fda_inspections/otsuka-pharmaceutical-development-commercialization-inc/74c1b27e-3864-4eed-8611-280f06b70f94)
- [FDA Inspection 1276733 - 2025-06-25](https://www.keypedia.com/records/fda_inspections/otsuka-pharmaceutical-development-commercialization-inc/f511ad3b-3616-4cda-bc99-e643315dc9a0)
- [FDA Inspection 1276733 - 2025-06-25](https://www.keypedia.com/records/fda_inspections/otsuka-pharmaceutical-development-commercialization-inc/049cfe1c-64c6-4c40-a870-c4b95f51b751)
- [FDA Inspection 868761 - 2014-03-18](https://www.keypedia.com/records/fda_inspections/otsuka-pharmaceutical-development-commercialization-inc/4ae736dc-c8ef-478e-819a-5439f8e8e120)

Company: https://www.keypedia.com/companies/otsuka-pharmaceutical-development-commercialization-inc/a1427d0e-e216-46ba-9158-bc52701a7a70

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c